Table 5 Data of patients receiving renal re-biopsy
Patient (No.) | Age/gender | ANCA types | Organs involved | Initial Scr (μmol/L) | Duration of induction therapy (months) | Scr at the beginning of maintenance therapy (μmol/L) | Scr at re-biopsy (μmol/L) | Time interval of the re-biopsy (months) | Renal biopsy findings | Scr at last follow-up (μmol/L) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 51/F | MPO | L,K,J | 638 | 8 | 134 | 157 | 34 | three cellular crescents, 10 cellular-fibrous crescents, 14 fibrous crescents in a total of 32 glomeruli | 131 |
2 | 21/F | MPO | S,K | 146 | 6 | 128 | 130 | 33 | one cellular crescent, 1 cellular-fibrous crescent, 3 fibrous crescents in a total of 11 glomeruli | 152 |
3 | 40/F | MPO | K | 77 | 6 | 98 | 102 | 85 | Three fibrous crescents in a total of 13 glomeruli | 104 |